Triterpene derivatives and endothelin-receptor antagonists conta

Organic compounds -- part of the class 532-570 series – Organic compounds – Carboxylic acid esters

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

562441, C07C21143

Patent

active

054631076

ABSTRACT:
Triterpene derivatives of the formula (I): ##STR1## wherein R.sup.1 is hydrogen or metabolic ester residue; and R.sup.2 is hydrogen or --R.sup.3 --R.sup.4 wherein R.sup.3 is --SO.sub.3 --, --CH.sub.2 COO--, --COCOO--, or --COR.sup.5 COO-- (R.sup.5 is lower alkylene or lower alkenylene), and R.sup.4 is hydrogen or metabolic ester residue or a pharmaceutically acceptable salt thereof, which have anti-endothelin activities and are useful in prophylaxis and treatment of diseases caused by excessive secretion of endothelin.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Triterpene derivatives and endothelin-receptor antagonists conta does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Triterpene derivatives and endothelin-receptor antagonists conta, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triterpene derivatives and endothelin-receptor antagonists conta will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1773669

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.